Literature DB >> 12270697

Up-regulation of FPR2, a chemotactic receptor for amyloid beta 1-42 (A beta 42), in murine microglial cells by TNF alpha.

Y H Cui1, Y Le, X Zhang, W Gong, K Abe, R Sun, J Van Damme, P Proost, J M Wang.   

Abstract

Human FPRL1 and its mouse homologue FPR2 are functional receptors for several exogenous and host-derived chemotactic peptides, including amyloid beta(42) (A beta(42)), a critical pathogenic factor in Alzheimer's disease. We investigated the effect of TNF alpha on the expression and function of FPR2 in mouse microglial cells, a crucial inflammatory cell type in the CNS. Primary murine microglia and a cell line N9 in resting state expressed low levels of FPR2 gene and lacked the response to chemotactic agonists for this receptor. Incubation with TNF alpha, however, increased microglial expression of FPR2 gene, in association with potent chemotactic responses to FPR2-specific agonists including A beta(42). The effect of TNF alpha was dependent on the p55 TNF alpha receptor and activation of MAP kinase p38. TNF alpha concomitantly down-regulated microglial response to the chemokine SDF-1 alpha. Thus, by selectively up-regulating FPR2 in microglia, TNF alpha has the capacity to amplify host response in inflammatory diseases in the CNS.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12270697     DOI: 10.1006/nbdi.2002.0517

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  19 in total

1.  Resolvin D1 and E1 promote resolution of inflammation in rat cardiac fibroblast in vitro.

Authors:  Aimeé Salas-Hernández; Claudio Espinoza-Pérez; Raúl Vivar; Jenaro Espitia-Corredor; José Lillo; Pablo Parra-Flores; Carlos F Sánchez-Ferrer; Concepción Peiró; Guillermo Díaz-Araya
Journal:  Mol Biol Rep       Date:  2021-01-18       Impact factor: 2.316

2.  Viral induction of central nervous system innate immune responses.

Authors:  J D Rempel; L A Quina; P K Blakely-Gonzales; M J Buchmeier; D L Gruol
Journal:  J Virol       Date:  2005-04       Impact factor: 5.103

3.  Immunomodulation via Toll-like Receptor 9: An Adjunct Therapy Strategy against Alzheimer's Disease?

Authors:  Maria Clara Selles; Juliana Tiemi Sato Fortuna; Luís Eduardo Santos
Journal:  J Neurosci       Date:  2017-05-10       Impact factor: 6.167

Review 4.  Microglial Aβ receptors in Alzheimer's disease.

Authors:  Yang Yu; Richard D Ye
Journal:  Cell Mol Neurobiol       Date:  2014-08-23       Impact factor: 5.046

5.  Androgen alleviates neurotoxicity of β-amyloid peptide (Aβ) by promoting microglial clearance of Aβ and inhibiting microglial inflammatory response to Aβ.

Authors:  Peng-Le Yao; Shu Zhuo; Hong Mei; Xiao-Fang Chen; Na Li; Teng-Fei Zhu; Shi-Ting Chen; Ji-Ming Wang; Rui-Xing Hou; Ying-Ying Le
Journal:  CNS Neurosci Ther       Date:  2017-09-20       Impact factor: 5.243

6.  Proinflammatory stimulants promote the expression of a promiscuous G protein-coupled receptor, mFPR2, in microvascular endothelial cells.

Authors:  Haiwei Mou; Zongmeng Li; Yan Kong; Bo Deng; Lihua Qian; Ji Ming Wang; Yingying Le
Journal:  Inflammation       Date:  2012-04       Impact factor: 4.092

Review 7.  Role of formyl peptide receptor-like 1 (FPRL1/FPR2) in mononuclear phagocyte responses in Alzheimer disease.

Authors:  Pablo Iribarren; Ye Zhou; Jinyue Hu; Yingying Le; Ji Ming Wang
Journal:  Immunol Res       Date:  2005       Impact factor: 2.829

8.  Role of toll-like receptor signalling in Abeta uptake and clearance.

Authors:  Kazuki Tahara; Hong-Duck Kim; Jing-Ji Jin; J Adam Maxwell; Ling Li; Ken-ichiro Fukuchi
Journal:  Brain       Date:  2006-09-19       Impact factor: 13.501

Review 9.  The Distinct Role of ADAM17 in APP Proteolysis and Microglial Activation Related to Alzheimer's Disease.

Authors:  Meng Qian; Xiaoqiang Shen; Huanhuan Wang
Journal:  Cell Mol Neurobiol       Date:  2015-06-29       Impact factor: 5.046

10.  Interleukin 10 and TNFalpha synergistically enhance the expression of the G protein-coupled formylpeptide receptor 2 in microglia.

Authors:  Pablo Iribarren; Keqiang Chen; Wanghua Gong; Edward H Cho; Stephen Lockett; Badarch Uranchimeg; Ji Ming Wang
Journal:  Neurobiol Dis       Date:  2007-05-05       Impact factor: 5.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.